126 related articles for article (PubMed ID: 1309761)
1. A vasopressin analog that binds but does not activate V1 or V2 vasopressin receptors is not internalized into cells that express V1 or V2 receptors.
Lutz W; Londowski JM; Sanders M; Salisbury J; Kumar R
J Biol Chem; 1992 Jan; 267(2):1109-15. PubMed ID: 1309761
[TBL] [Abstract][Full Text] [Related]
2. Internalization of vasopressin analogs in kidney and smooth muscle cells: evidence for receptor-mediated endocytosis in cells with V2 or V1 receptors.
Lutz W; Sanders M; Salisbury J; Kumar R
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6507-11. PubMed ID: 2144348
[TBL] [Abstract][Full Text] [Related]
3. The synthesis and biological activity of four novel fluorescent vasopressin analogs.
Lutz WH; Londowski JM; Kumar R
J Biol Chem; 1990 Mar; 265(8):4657-63. PubMed ID: 2155234
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of a biotinylated vasopressin analog.
Lutz WH; Londowski JM; Kumar R
Peptides; 1990; 11(4):687-91. PubMed ID: 2172938
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles.
Maggi M; Kassis S; Malozowski S; Guardabasso V; Rodbard D
Proc Natl Acad Sci U S A; 1986 Dec; 83(23):8824-8. PubMed ID: 2947237
[TBL] [Abstract][Full Text] [Related]
6. Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profile.
Colson PH; Virsolvy A; Gaudard P; Charrabi A; Corbani M; Manière MJ; Richard S; Guillon G
Pharmacol Res; 2016 Nov; 113(Pt A):257-264. PubMed ID: 27586252
[TBL] [Abstract][Full Text] [Related]
7. Isolation and genetic characterization of a renal epithelial cell mutant defective in vasopressin (V2) receptor binding and function.
Luzius H; Jans DA; Jans P; Fahrenholz F
Exp Cell Res; 1991 Aug; 195(2):478-84. PubMed ID: 1649058
[TBL] [Abstract][Full Text] [Related]
8. Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligands.
Phillips PA; Abrahams JM; Kelly JM; Mooser V; Trinder D; Johnston CI
Endocrinology; 1990 Mar; 126(3):1478-84. PubMed ID: 2307115
[TBL] [Abstract][Full Text] [Related]
9. Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.
Stassen FL; Heckman G; Schmidt D; Papadopoulos MT; Nambi P; Sarau H; Aiyar N; Gellai M; Kinter L
Mol Pharmacol; 1988 Feb; 33(2):218-24. PubMed ID: 2828915
[TBL] [Abstract][Full Text] [Related]
10. Lateral mobility of the antagonist-occupied V2 vasopressin receptor in membranes of renal epithelial cells.
Pavo I; Jans DA; Peters R; Penke B; Fahrenholz F
Biochim Biophys Acta; 1994 Sep; 1223(2):240-6. PubMed ID: 8086494
[TBL] [Abstract][Full Text] [Related]
11. Oxytocin receptors from LLC-PK1 cells: expression in Xenopus oocytes.
Cantau B; Barjon JN; Chicot D; Baskevitch PP; Jard S
Am J Physiol; 1990 Apr; 258(4 Pt 2):F963-72. PubMed ID: 2158746
[TBL] [Abstract][Full Text] [Related]
12. The adenylate cyclase-coupled vasopressin V2-receptor is highly laterally mobile in membranes of LLC-PK1 renal epithelial cells at physiological temperature.
Jans DA; Peters R; Zsigo J; Fahrenholz F
EMBO J; 1989 Sep; 8(9):2481-8. PubMed ID: 2531084
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin receptor-mediated endocytosis: current view.
Lutz W; Salisbury JL; Kumar R
Am J Physiol; 1991 Jul; 261(1 Pt 2):F1-13. PubMed ID: 1650143
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and functional characterization of V2 [8-lysine] vasopressin and oxytocin receptors from a pig kidney cell line.
Gorbulev V; Büchner H; Akhundova A; Fahrenholz F
Eur J Biochem; 1993 Jul; 215(1):1-7. PubMed ID: 8393786
[TBL] [Abstract][Full Text] [Related]
15. Vascular vasopressin receptors mediate inhibition of beta adrenergic receptor-induced cyclic AMP accumulation.
Nambi P; Whitman M; Stassen FL; Crooke ST
J Pharmacol Exp Ther; 1986 Apr; 237(1):143-6. PubMed ID: 3007735
[TBL] [Abstract][Full Text] [Related]
16. Vasopressin receptor-adenylate cyclase interactions. Studies in an intact cultured renal epithelial cell line (LLC-PK1).
Skorecki KL; Verkman AS; Ausiello DA
Miner Electrolyte Metab; 1986; 12(1):64-70. PubMed ID: 3007962
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin V1 receptors on the principal cells of the rabbit cortical collecting tubule. Stimulation of cytosolic free calcium and inositol phosphate production via coupling to a pertussis toxin substrate.
Burnatowska-Hledin MA; Spielman WS
J Clin Invest; 1989 Jan; 83(1):84-9. PubMed ID: 2536047
[TBL] [Abstract][Full Text] [Related]
18. Internalization of V2-vasopressin receptors in LLC-PK1-cells: evidence for receptor-mediated endocytosis.
Hocher B; Merker HJ; Dürr JA; Schiller S; Gross P; Hensen J
Biochem Biophys Res Commun; 1992 Aug; 186(3):1376-83. PubMed ID: 1387309
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II potentiates vasopressin-dependent cAMP accumulation in CHO transfected cells. Mechanisms of cross-talk between AT1A and V2 receptors.
Klingler C; Ancellin N; Barrault MB; Morel A; Buhler JM; Elalouf JM; Clauser E; Lugnier C; Corman B
Cell Signal; 1998 Jan; 10(1):65-74. PubMed ID: 9502119
[TBL] [Abstract][Full Text] [Related]
20. Effect of bacitracin on the degradation of a vasopressin receptor ligand with high affinity for the V1 and V2 vasopressin isoreceptors.
Hocher B; Dürr JA; Hensen J
Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):61-4. PubMed ID: 8003578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]